Contact
Please use this form to send email to PR contact of this press release:
InterveXion Licenses Asian Rights to Novel Anti-Methamphetamine Antibody to Ascent Therapeutics
TO:
Misty Stevens, PhD
InterveXion Therapeutics
501-554-2377